Blog

Keeping your hands clean is one of the easiest ways to reduce the spread of the new coronavirus that causes COVID-19 . It can also help help protect you from flu, colds and other respiratory infections . It also helps prevent foodborne illnesses (such as salmonella) while cooking. One study shows people touch their faces on an average of 23 times an hour. 1 Your hands come in contact with many germs, and when you touch your face, you increase your chances of getting sick. Keeping them clean...

Update – July 20, 2020 We have updated this blog post to reflect which states have ended or extended their open enrollment periods. With the spread of the new coronavirus (COVID-19) , many uninsured people are concerned about medical costs if they get sick. Several states have opened up their health care exchanges for a special open enrollment period. Some states are also giving people who’ve lost their jobs the chance to enroll. If you need insurance, you can enroll in the following states:...

Updated 7/16: The 2019 novel coronavirus that causes COVID-19 is still highly active through the U.S. Read the current recommendations for people with asthma including symptoms, wearing masks and effective disinfecting of surfaces.

Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. today announced the launch of ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder, the first and only digital rescue inhaler indicated in patients four years or older for the treatment or prevention of bronchospasm who have reversible obstructive airway disease, and for prevention of exercise-induced bronchospasm (EIB).

Information from AAFA’s Ask the Allergist is not a substitute for a consultation with a health care professional. Always talk with your own doctor before making changes to your asthma or allergy management plan. This question appeared in our spring/summer 2020 issue of freshAAIR Magazine, our FREE digital magazine featuring news and resources on asthma and allergies. Read the most recent issue. Question: When using oral steroids daily for the treatment of asthma, what is considered a “high...

The Asthma and Allergy Foundation of America (AAFA) conducts and promotes patient-centered research to help you. This means your beliefs, preferences and needs are at the center of our research. Your input drives our advocacy work, guides our education programs and supports our community. Recently, we’ve studied the following topics: Symptoms of anaphylaxis in infants and toddlers Eczema burdens and people’s experiences with treatments Impact of COVID-19 on people with asthma and allergy Air...

Due to the coronavirus pandemic , families face uncertainty related to health, finances and overall well-being. The Asthma and Allergy Foundation of America (AAFA) surveyed 2,695 people to understand the impact of COVID-19 on asthma and allergy communities. The survey revealed the reach of the virus, how families are protecting themselves and the challenges families face specific to asthma and allergies. AAFA will use the results to target communication, education and advocacy efforts. Of...

U.S. systems have historically failed Black Americans and other marginalized groups. AAFA's goal is to dramatically reduce the burden of asthma and allergies for underserved groups within five years.

We are honored that the Asthma and Allergy Foundation of America’s blog has again been named one of the best asthma blogs by Healthline for 2020! Healthline is a health site with information on many health topics. We have received this honor since 2015 when we started our blog! Comment below to tell us what you want to see more of on our blog. We could not have received this honor without all of our supporters and members. Our blog will continue to bring you information about asthma and...

Samsung’s Cube Air Purifier earns asthma & allergy friendly® Certification. The Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL) has announced that Samsung’s Cube Air Purifier has earned asthma & allergy friendly® Certification.

The U.S. Food and Drug Administration (FDA) approved Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent is the only biologic medicine approved for this patient population.

On May 22, 2020, the Food and Drug Administration (FDA) relaxed labeling guidelines for food companies . This is a temporary measure because of food supply issues due to COVID-19 (the new coronavirus). The Asthma and Allergy Foundation of America (AAFA) met with the FDA to talk about how this will affect the food allergy community. After the meeting, we organized a joint letter with other food allergy advocacy organizations to send to the FDA. The letter addresses the FDA’s short-term food...